Results

Clinically Proven Results:

For patients with type 2 diabetes, the OPTIFAST ® VLCD program has also been shown to normalise beta cell function and hepatic insulin sensitivity 3
After 26 weeks on the Optifast program, men and women lost an average 25% of their starting body weight6
The OPTIFAST ® VLCD program can help patients achieve substantial and rapid weight loss 4
On average, patients achieve a weight loss of 1.5–2.5 kg/week 2
With lifestyle changes, weight loss can be sustained into the future 4
Weight loss with Optifast can lower cholesterol and triglyceride levels, blood glucose levels, blood pressure and waist size.8

Helps deliver substantial and rapid weight loss 1,2 A nutritionally-complete total food replacement program
Restricts energy intake to less than 800 calories a day
Can be used safely in patients with various chronic diseases 5
Maintains patients’ vital nutrition and health 2–4
Side effects are usually transient.

Drawert S et al. Obes Res 1996;4(Suppl 1):66S.
Mustajoki P and Pekkarinen T. Obes Rev 2001;2:61–72.
Lim EL et al. Diabetologia-2011;54:2506–14.
Delbridge E and Proietto J. Asia Pac J Clin Nutr 2006;15:49–54
Purcell K, Sumithran P, Prendergast LA, et al. The Effect of Rate of Weight Loss on Long-Term Weight Management: A Randomized Controlled Trial. Lancet Diabetes Endocrinol. 2014;2:954-62
Hammond RA, Levine R. The economic impact of obesity in the United States. Diabetes, metabolic syndrome and obesity : targets and therapy. 2010;3:285-295. doi:10.2147/DMSOTT.S7384.
Steven S, Hollingsworth KG, Al-Mrabeh A, Avery L, Aribisala B, Caslake M, Taylor R. Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders. Diabetes Care 2016 May;39(5):808-15.